anthralin has been researched along with etretinate in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (73.08) | 18.7374 |
1990's | 4 (15.38) | 18.2507 |
2000's | 1 (3.85) | 29.6817 |
2010's | 2 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bilhou-Nabera, C; Fontan, I; Guillot, P; Maleville, J; Renaud, P; Taieb, A; Viard, E | 1 |
Brun, P; Czernielewski, J; Juhlin, L; Shroot, S | 1 |
Cunliffe, WJ; Holland, DB; Roberts, SG; West, MR; Wood, EJ | 1 |
Cunliffe, WJ; Holland, DB; Turner, DM; Wood, EJ | 1 |
Bleehen, SS; Dawson, RA; MacNeil, S; Tomlinson, S; Tucker, WF | 1 |
Going, SM | 1 |
Kietzmann, M; Lubach, D | 1 |
Vardy, D; Werner, E | 1 |
Cockerline, EB; Dunn, ML; Rice, MR | 1 |
Fritsch, P; Hönigsmann, H | 1 |
Braun-Falco, O; Galosi, A; Ruzicka, T | 1 |
Berro, V; Sher, B; Sher, MA | 1 |
Tan, YC; Thirumoorthy, T; Wong, BY | 1 |
Watson, A | 1 |
Schwender, CF; Sircar, JC | 1 |
Lubach, D | 1 |
Christophers, E | 1 |
Abel, EA; Charuworn, A; Farber, EM | 1 |
Rajan, VS; Thirumoorthy, T | 1 |
Ehmann, CW; Voorhees, JJ | 1 |
Akhurst, RJ; Mackie, RM; Stables, GS; Watts, P | 1 |
Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G | 1 |
Barthel, B; Brockmeyer, NH; Frühauf, S; Goos, M; Mertins, L | 1 |
Benes, P; Benz, RE; Färber, L; Langendorf, Y; Schopf, RE | 1 |
4 review(s) available for anthralin and etretinate
Article | Year |
---|---|
[Linear porokeratosis of Mibelli in monozygotic twin girls].
Topics: Anthralin; Child; Diseases in Twins; DNA Fingerprinting; Etretinate; Female; Humans; Keratosis; Laser Therapy; Skin; Twins, Monozygotic | 1991 |
ABC of dermatology. Treatment of psoriasis.
Topics: Administration, Topical; Anthralin; Coal Tar; Etretinate; Humans; Methotrexate; Psoriasis; PUVA Therapy; Ultraviolet Therapy | 1987 |
Combination phototherapy--a critical appraisal.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anthralin; Coal Tar; Combined Modality Therapy; Etretinate; Evaluation Studies as Topic; Humans; Methotrexate; Mice; Photochemotherapy; Psoriasis; PUVA Therapy; Retinoids; Ultraviolet Therapy | 1986 |
International studies of the efficacy of etretinate in the treatment of psoriasis.
Topics: Anthralin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Etretinate; Humans; Psoriasis; PUVA Therapy; Tretinoin; Ultraviolet Therapy | 1982 |
3 trial(s) available for anthralin and etretinate
Article | Year |
---|---|
International studies of the efficacy of etretinate in the treatment of psoriasis.
Topics: Anthralin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Etretinate; Humans; Psoriasis; PUVA Therapy; Tretinoin; Ultraviolet Therapy | 1982 |
Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Topics: Administration, Cutaneous; Adult; Anthralin; Arthritis, Psoriatic; Blood Pressure; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Etretinate; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Nail Diseases; Psoriasis; Recurrence; Severity of Illness Index; Skin; Time Factors; Treatment Outcome | 1995 |
A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Affinity Labels; Aged; Anthralin; Anti-Inflammatory Agents; Azides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Dermatologic Agents; Erythrocyte Membrane; Etretinate; Female; Humans; Keratolytic Agents; Male; Middle Aged; Protein Binding; Psoriasis; Retinoids; Severity of Illness Index | 2002 |
20 other study(ies) available for anthralin and etretinate
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin.
Topics: Adenosine Triphosphatases; Adult; Aged; Anthracenes; Anthralin; Antibodies, Monoclonal; Cell Count; Etretinate; Female; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Langerhans Cells; Male; Middle Aged; Photochemotherapy; Psoriasis; PUVA Therapy; Staining and Labeling | 1985 |
Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis.
Topics: Anthralin; Calcium; Cell Differentiation; Cell Division; Densitometry; Electrophoresis, Polyacrylamide Gel; Etretinate; Female; Humans; Hydroxycholecalciferols; Hydroxyurea; Immunoblotting; Keratins; Male; Phosphates; Psoriasis; PUVA Therapy; Skin | 1989 |
Keratin gene expression during the resolution of psoriatic plaques: effect of dithranol, PUVA, etretinate and hydroxyurea regimens.
Topics: Anthralin; Densitometry; Electrophoresis; Epidermis; Etretinate; Female; Gene Expression; Humans; Hydroxyurea; Immunoblotting; Keratins; Male; Molecular Weight; Psoriasis; PUVA Therapy | 1989 |
An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
Topics: Animals; Anthracenes; Anthralin; Calmodulin; Cattle; Coal Tar; Etretinate; Hydrocortisone; In Vitro Techniques; Methotrexate; Methoxsalen; Oxidation-Reduction; Phosphoric Diester Hydrolases; Psoriasis | 1986 |
Effects of treatment with dithranol, etretinate and a combination of dithranol and etretinate on epidermal metabolism and histology. Mouse tail assay.
Topics: Animals; Anthralin; Cell Differentiation; DNA; Drug Interactions; Epidermal Cells; Epidermis; Etretinate; Histidine; Leucine; Male; Mice; Protein Biosynthesis; Tail; Thymine Nucleotides | 1988 |
[Combination of etretinate and dithrocream for severe psoriasis].
Topics: Adolescent; Anthralin; Drug Therapy, Combination; Etretinate; Female; Humans; Ointments; Psoriasis | 1988 |
Treatment options for psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Coal Tar; Dermatologic Agents; Emollients; Etretinate; Humans; Photochemotherapy; Psoriasis; Ultraviolet Therapy | 1988 |
[What is established in the treatment of psoriasis?].
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Etretinate; Glucocorticoids; Humans; Mercury; Methotrexate; Psoriasis; PUVA Therapy; Tars; Ultraviolet Therapy | 1987 |
Treatment of psoriasis. Results achieved by the Johannesburg Hospital Psoriasis Clinic.
Topics: Adult; Aged; Anthralin; Coal Tar; Etretinate; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Ultraviolet Therapy | 1986 |
The day-care centre in the management of psoriasis.
Topics: Ambulatory Care; Anthralin; Day Care, Medical; Etretinate; Humans; Psoriasis; PUVA Therapy | 1985 |
The treatment of psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antineoplastic Agents; Coal Tar; Etretinate; Glucocorticoids; Humans; Psoriasis | 1985 |
Antipsoriatic drugs as inhibitors of soybean lipoxygenase. A possible mode of action.
Topics: Anthralin; Arachidonate Lipoxygenases; Etretinate; Glycine max; Lipoxygenase Inhibitors; Mycophenolic Acid; Psoriasis; Resorcinols; Salicylates; Tretinoin | 1983 |
[Psoriasis vulgaris. 2. Problems of the psoriatic patient--therapeutic possibilities].
Topics: Anthralin; Etretinate; Heliotherapy; Humans; Psoriasis; PUVA Therapy | 1983 |
[Therapy of psoriasis].
Topics: Anthralin; Etretinate; Humans; Methotrexate; Psoriasis; PUVA Therapy; Salicylates | 1983 |
Recent advances in the treatment of psoriasis.
Topics: Anthralin; Coal Tar; Drug Therapy, Combination; Etretinate; Humans; Methotrexate; Psoriasis; PUVA Therapy; Razoxane; Tretinoin; Ultraviolet Therapy | 1983 |
Current trends in the treatment of psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Drug Therapy, Combination; Etretinate; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Time Factors; Tretinoin | 1983 |
Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy.
Topics: Anthralin; Coal Tar; Epidermis; Etretinate; Gene Expression; Humans; Immunohistochemistry; In Situ Hybridization; Psoriasis; PUVA Therapy; RNA; Steroids; Transforming Growth Factor alpha; Ultraviolet Therapy | 1994 |
Effects of antipsoriatic therapies on hepatic microsomal enzyme activity in patients with psoriasis.
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Antipyrine; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Etretinate; Humans; Keratolytic Agents; Metabolic Clearance Rate; Methoxsalen; Microsomes, Liver; Psoriasis; PUVA Therapy; Ultraviolet Rays | 1998 |